Unity Biotechnology Inc (UBX) stock is lower by -60.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives UBX stock a score of 32 out of a possible 100.
That rank is influenced by a short-term technical score of 9. UBX's rank also includes a long-term technical score of 10.
UBX has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on UBX!
Unity Biotechnology Inc (UBX) stock has risen 3.39% while the S&P 500 is lower by -0.06% as of 10:43 AM on Tuesday, Jan 23. UBX is higher by $0.06 from the previous closing price of $1.72 on volume of 12,135 shares. Over the past year the S&P 500 is higher by 20.59% while UBX is lower by -60.96%. UBX lost -$3.65 per share in the over the last 12 months.
Click Here to get the full Stock Report for Unity Biotechnology Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
